Valeritas, Inc.

we are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. we designed our first commercialized product, the v-go wearable insulin delivery device, or v-go, to help patients with type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals. v-go is indicated for continuous subcutaneous infusion of insulin over 24 hours at preset rates and on-demand bolus dosing in two-unit increments in adult patients requiring insulin. v-go is a small, discreet and easy-to-use disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. v-go enables patients to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. v-go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin (fast-acting) at a continuous preset (background) basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. in numerous real-world analyses v-go has consistently shown to lower a1c’s with less insulin. the discreet and convenient basal-bolus insulin delivery method provided by v-go empowers patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections. v-go is cleared for use in the united states and the e.u. is commercially available in the united states.

Trova indirizzi email

Provatelo velocemente con tomba.io. tomba.io.

Trova indirizzi email da un elencoInizia con Google